A patient alleging Invokana kidney damage has come forward to file the latest in a series of lawsuits against the drug’s manufacturer. Many patients have allegedly experienced Invokana kidney damage and argue that they were never fully warned about the risks of taking this medication prior to receiving a prescription.
Invokana Kidney Damage Chief Among Patient Adverse Event Reports
Many doctors and patients who have become aware of Invokana kidney damage argue that the company is responsible for failing to disclose the serious risks to the medical community at large.
Any type of serious kidney issue may be difficult for a patient to identify, meaning that it could develop into more severe situations before it is diagnosed. Any patient who suffered these injuries likely also suffered additional pain and medical treatments. If not caught early, kidney problems can be life-threatening.
Information provided by manufacturers about the dangers of a drug is necessary for physicians and their patients to make decisions about using a particular medication.
According to the Invokana kidney damage lawsuit, the medication has been designed, marketed and sold for years despite the fact that the manufacturers were aware of the high risk of severe side effects for diabetic patients. As explained in studies and patient reports in the Invokana kidney damage lawsuit, Invokana significantly increased the risk of stroke, severe kidney failure, diabetic ketoacidosis and heart attack for those patients who had diabetes.
The Invokana kidney damage lawsuit says that the manufacturers were aware of these risks, but failed to disclose them to the public and put patients at risk as a result. The manufacturers are also accused of aggressively marketing this medication despite its serious side effects.
The new drug application was submitted for Invokana by the manufacturers in May of 2012, and it was approved in March 2013 for the treatment of Type-2 Diabetes. However, the Invokana kidney damage lawsuit says that defendants were aware of the possibility for Invokana to cause kidney failure, but failed to properly disclose those risks. A safety communication was issued by the FDA in 2015 due to the number of adverse event reports linking Invokana with diabetic ketoacidosis. Additionally, some of the patients who have been harmed by Invokana kidney damage have come forward to initiate lawsuits.
The plaintiff in this Invokana kidney damage lawsuit began taking the medication in April of 2015 to treat diabetes but suffered diabetic ketoacidosis in January of 2016 leading to hospitalization and other invasive medical treatments. If you or someone you know believes you have grounds for an Invokana kidney damage lawsuit, you need to consult with the experienced attorneys at Bradley/Grombacher today about your rights. Fill out the form on this page to learn more.
The Invokana kidney damage lawsuit is Case No. 3:18-CV-00827-BRM-LHG filed in the United States District Court, District of New Jersey.
Note: Bradley/Grombacher is not representing the plaintiff in this lawsuit.